Therapeutic potentials of silver nanoparticle complex of α-lipoic acid

Nanomaterials and Nanotechnology

Volumn 1, Issue 2, 2011, Pages 17-24

  Ramachandran, Lakshmy ^a   Nair, Cherupally Krishnan Krishnan ^b  

^a AMALA CANCER RESEARCH CENTRE   (India)

^b India   (India)

Author keywords

Anti tumor; Antiinflammatory; Lipoic acid; Radiotherapy; Silver nanoparticle

Indexed keywords

GAMMA RAYS; MAMMALS; METAL NANOPARTICLES; RADIOTHERAPY; SILVER COMPOUNDS; SOLUTIONS; TUMORS;

ANTI-INFLAMMATORIES; ANTI-INFLAMMATORY ACTIVITY; ANTI-TUMORS; CANCER RADIOTHERAPIES; DPPH RADICAL SCAVENGING ACTIVITIES; LIPOIC ACIDS; RADIATION EXPOSURE; THERAPEUTIC POTENTIALS;

SILVER NANOPARTICLES;

EID: 84888005217     PISSN: None     EISSN: 18479804     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. C. K. K. Nair, D. K. Parida, and T. Nomura, "Radioprotectors in radiotherapy," Journal of radiation research, vol. 42, pp. 21-37 2001.
2. S. N. Upadhyay, B. S. Dwarakanath, and T. Ravindranath, "Chemical Radioprotectors," Defence Science Journal, vol. 55, pp. 403-425, 2005.
3. S. C. Tjong and H. Chen, "Nanocrystalline materials and coatings," Materials Science and Engineering: R: Reports, vol. 45, pp. 1-88, 2004.
4. B. A. Rzigalinski, "Nanoparticles and cell longevity," Technol Cancer Res Treat, vol. 4, pp. 651-9, Dec 2005.
5. S. S. Ali, J. I. Hardt, K. L. Quick, J. S. Kim-Han, B. F. Erlanger, T. T. Huang, C. J. Epstein, and L. L. Dugan, "A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties," Free Radic Biol Med, vol. 37, pp. 1191-202, Oct 15 2004.
6. R. W. Tarnuzzer, J. Colon, S. Patil, and S. Seal, "Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage," Nano Letters, vol. 5 pp. 2573-2577, 2005.
7. S. Trajkovic, S. Dobric, V. Jacevic, V. Dragojevic-Simic, Z. Milovanovic, and A. Dordevic, "Tissue-protective effects of fullerenol C60(OH)24 and amifostine in irradiated rats," Colloids Surf B Biointerfaces, vol. 58, pp. 39-43, Jul 1 2007.
8. B. Daroczi, K. Gabor, M. F. Mary, W. C. Jeffrey, R. Ulrich, P. Adam, and Dicker, "In vivo radioprotection by the fullerene nanoparticle DF-1as assessed in a zebrafish model," Clinical Cancer Research, vol. 12, 2006.
9. D. Schubert, R. Dargusch, J. Raitano, and S. W. Chan, "Cerium and yttrium oxide nanoparticles are neuroprotective," Biochem Biophys Res Commun, vol. 342, pp. 86-91, Mar 31 2006.
10. S. Deshpande, S. Patil, S. V. N. T. Kuchibhatla, and S. Seal, "Size dependency variation in lattice parameter and valency states in nanocrystalline cerium oxide," Applied Physics Letters, vol. 87, pp. 133113-3, 2005.
11. K. K. Y. Wong, S. O. F. Cheung, L. Huang, J. Niu, C. Tao, C.-M. Ho, C.-M. Che, and P. K. H. Tam, "Further Evidence of the Anti-inflammatory Effects of Silver Nanoparticles," ChemMedChem, vol. 4, pp. 1129-1135, 2009.
12. P. L. Nadworny, J. Wang, E. E. Tredget, and R. E. Burrell, "Anti-inflammatory activity of nanocrystalline silver in a porcine contact dermatitis model," Nanomedicine : nanotechnology, biology, and medicine, vol. 4, pp. 241-251, 09/01 2008.
13. K. C. Bhol, J. Alroy, and P. J. Schechter, "Antiinflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model," Clinical and Experimental Dermatology, vol. 29, pp. 282-287, 2004.
14. K. Bhol and P. Schechter, "Effects of Nanocrystalline Silver (NPI 32101) in a Rat Model of Ulcerative Colitis," Digestive Diseases and Sciences, vol. 52, pp. 2732-2742, 2007.
15. P. L. Nadworny, B. K. Landry, J. Wang, E. E. Tredget, and R. E. Burrell, "Does nanocrystalline silver have a transferable effect?," Wound Repair and Regeneration, vol. 18, pp. 254-265.
16. P. L. Nadworny, J. Wang, E. E. Tredget, and R. E. Burrell, "Anti-inflammatory activity of nanocrystalline silver-derived solutions in porcine contact dermatitis," Journal of inflammation (London, England), vol. 7, p. 13.
17. J. Banerjee and N. R. T, "Biosynthesis of silver nanoparticles from Syzygium cumini (l.) Seed extract and evaluation of their in vitro antioxidant activities," Digest Journal of Nanomaterials and Biostructures vol. 6, pp. 961 - 968, July - September 2011.
18. R. Warriner and R. Burrell, "Infection and the chronic wound: a focus on silver," Adv Skin Wound Care, vol. 18 Suppl 1, pp. 2-12, Oct 2005.
19. J. B. Wright, K. Lam, A. G. Buret, M. E. Olson, and R. E. Burrell, "Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing," Wound Repair Regen, vol. 10, pp. 141-51, May-Jun 2002.
20. R. Bhattacharya and P. Mukherjee, "Biological properties of "naked" metal nanoparticles," Adv Drug Deliv Rev, vol. 60, pp. 1289-306, Aug 17 2008.
21. K. Kalishwaralal, S. Barathmanikanth, S. R. Pandian, V. Deepak, and S. Gurunathan, "Silver nano - a trove for retinal therapies," J Control Release, vol. 145, pp. 76- 90, Jul 14.
22. H. H. Lara, N. V. Ayala-Nunez, L. Ixtepan-Turrent, and C. Rodriguez-Padilla, "Mode of antiviral action of silver nanoparticles against HIV-1," J Nanobiotechnology, vol. 8, p. 1.
23. R. W. Sun, R. Chen, N. P. Chung, C. M. Ho, C. L. Lin, and C. M. Che, "Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells," Chem Commun (Camb), pp. 5059- 61, Oct 28 2005.
24. S. Sheikpranbabu, K. Kalishwaralal, D. Venkataraman, S. H. Eom, J. Park, and S. Gurunathan, "Silver nanoparticles inhibit VEGF-and IL-1betainduced vascular permeability via Src dependent pathway in porcine retinal endothelial cells," J Nanobiotechnology, vol. 7, p. 8, 2009.
25. S. Sheikpranbabu, K. Kalishwaralal, K. J. Lee, R. Vaidyanathan, S. H. Eom, and S. Gurunathan, "The inhibition of advanced glycation end-productsinduced retinal vascular permeability by silver nanoparticles," Biomaterials, vol. 31, pp. 2260-71, Mar.
26. F. G. Rutberg, M. V. Dubina, V. A. Kolikov, F. V. Moiseenko, E. V. Ignat'eva, N. M. Volkov, V. N. Snetov, and A. Y. Stogov, "Effect of silver oxide nanoparticles on tumor growth in vivo," Dokl Biochem Biophys, vol. 421, pp. 191-3, Jul-Aug 2008.
27. J. Bustamante, J. K. Lodge, L. Marcocci, H. J. Tritschler, L. Packer, and B. H. Rihn, "Alpha-lipoic acid in liver metabolism and disease," Free Radic Biol Med, vol. 24, pp. 1023-39, Apr 1998.
28. V. E. Kagan, A. Shvedova, E. Serbinova, S. Khan, C. Swanson, R. Powell, and L. Packer, "Dihydrolipoic acid--a universal antioxidant both in the membrane and in the aqueous phase: Reduction of peroxyl, ascorbyl and chromanoxyl radicals," Biochemical Pharmacology, vol. 44, pp. 1637-1649, 1992.
29. D. Malinska and K. Winiarska, "[Lipoic acid: characteristics and therapeutic application]," Postepy Hig Med Dosw (Online), vol. 59, pp. 535-43, 2005.
30. Y.-S. Ho, C.-S. Lai, H.-I. Liu, S.-Y. Ho, C. Tai, M.-H. Pan, and Y.-J. Wang, "Dihydrolipoic acid inhibits skin tumor promotion through anti-inflammation and anti-oxidation," Biochemical Pharmacology, vol. Volume 73, 2007.
31. Y.-J. Wang, M.-C. Yang, and M.-H. Pan, "Dihydrolipoic acid inhibits tetrachlorohydroquinoneinduced tumor promotion through prevention of oxidative damage," Food and Chemical Toxicology vol. Volume 46, pp. 3739-3748, 2008.
32. D. Akpinar, P. Yargicoglu, N. Derin, Y. Aliciguzel, and A. Agar, "The effect of lipoic acid on antioxidant status and lipid peroxidation in rats exposed to chronic restraint stress," Physiological Research vol. 57, pp. 893-901, 2008.
33. G. R. Haenen and A. Bast, "Scavenging of hypochlorous acid by lipoic acid," Biochem Pharmacol, vol. 42, pp. 2244-6, Nov 6 1991.
34. L. Packer, E. H. Witt, and H. J. Tritschler, "alpha- Lipoic acid as a biological antioxidant," Free Radic Biol Med, vol. 19, pp. 227-50, Aug 1995.
35. K. Manda, M. Ueno, and K. Anzai, "Memory impairment, oxidative damage and apoptosis induced by space radiation: Ameliorative potential of [alpha]- lipoic acid," Behavioural Brain Research, vol. 187, pp. 387-395, 2008.
36. K. Manda, M. Ueno, T. Moritake, and K. Anzai, "Radiation-induced cognitive dysfunction and cerebellar oxidative stress in mice: protective effect of alpha-lipoic acid," Behav Brain Res, vol. 177, pp. 7-14, Feb 12 2007.
37. L. Ramachandran and C. K. K. Nair, "Protection against genotoxic damages following whole body gamma radiation exposure in mice by lipoic acid," Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 724, pp. 52-58, 2011.
38. D. K. Chandrasekharan, P. K. Khanna, and C. K. Nair, "Cellular radioprotecting potential of glyzyrrhizic acid, silver nanoparticle and their complex," Mutat Res, vol. 723, pp. 51-7, Jul 14.
39. G. G. Nair, S. S, and C. K. K. Nair, "Silver Nanoparticle-Gallic acid Complex as an Adjuvant in Tumour Radiotherapy: A Preclinical Evaluation. ," in Proceedings of the International Conference on Nanoscience and Technology in Chemistry, Health, Environment and Energy, K. L. D and D. S, Eds. New Delhi, India: Tata McGraw Hill Education Pvt. Ltd, 2010, pp. 217-221.
40. D. K. Chandrasekharan, T. V. Kagiya, and C. K. K. Nair, "Radiation protection by 6-palmitoyl ascorbic acid-2-glucoside: studies on DNA damage in vitro, ex vivo, in vivo and oxidative stress in vivo," Journal of Radiation Research, vol. 50, pp. 203-212, 2009.
41. P. K. Khanna, N. Singh, D. Kulkarni, S. Deshmukh, S. Charan, and P. V. Adhyapak, "Water based simple synthesis of re-dispersible silver nano-particles," Materials Letters, vol. 61, pp. 3366-3370, 2007.
42. A. von Gadow, E. Joubert, and C. F. Hansmann, "Comparison of the Antioxidant Activity of Aspalathin with That of Other Plant Phenols of Rooibos Tea (Aspalathus linearis), α-Tocopherol, BHT, and BHA," Journal of Agricultural and Food Chemistry, vol. 45, pp. 632-638, 03/01 1997.
43. P. Uma Devi, "Normal tissue protection in cancer therapy--progress and prospects," Acta Oncol, vol. 37, pp. 247-52, 1998.
44. R. Konwarh, B. Gogoi, R. Philip, M. A. Laskar, and N. Karak, "Biomimetic preparation of polymersupported free radical scavenging, cytocompatible and antimicrobial "green" silver nanoparticles using aqueous extract of Citrus sinensis peel," Colloids and Surfaces B: Biointerfaces, vol. 84, pp. 338-345.
45. R. Maiti and N. K. Agrawal, "Atherosclerosis in diabetes mellitus: role of inflammation," Indian J Med Sci, vol. 61, pp. 292-306, May 2007.
46. H. Ohshima and H. Bartsch, "Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis," Mutat Res, vol. 305, pp. 253-64, Mar 1 1994.
47. R. J. Stevens, K. M. Douglas, A. N. Saratzis, and G. D. Kitas, "Inflammation and atherosclerosis in rheumatoid arthritis," Expert Rev Mol Med, vol. 7, pp. 1-24, May 6 2005.
48. S. S. Virani, V. R. Polsani, and V. Nambi, "Novel markers of inflammation in atherosclerosis," Curr Atheroscler Rep, vol. 10, pp. 164-70, Apr 2008.
49. M. el-Ghazaly, S. Kenawy, M. T. Khayyal, H. Roushdy, and S. Saleh, "Effect of exposure to radiation on the inflammatory process and its influence by diclofenac," Br J Pharmacol, vol. 85, pp. 45-50, May 1985.
50. M. El-Ghazaly, S. Saleh, S. Kenawy, H. M. Roushdy, and M. T. Khayyal, "The protective value of piroxicam on the enhanced inflammatory response after whole body irradiation," Pharmacol Res Commun, vol. 18, pp. 563-80, Jun 1986.
51. M. A. El-Ghazaly and M. T. Khayyal, "The use of aqueous propolis extract against radiation-induced damage," Drugs Exp Clin Res, vol. 21, pp. 229-36, 1995.
52. M. T. Khayyal, M. El-Ghazaly, A. S. El-Khatib, and A. Hatem, "Tolerability of mofebutazone in asthmatic patients," Int J Clin Pharmacol Res, vol. 15, pp. 145-51, 1995.
53. P. Cole, "Evaluating clinical outcomes of respiratory infection," Int J Antimicrob Agents, vol. 3 Suppl 1, pp. S15-9, Nov 1993.
54. T. J. FitzGerald, J. Aronowitz, M. Giulia Cicchetti, G. Fisher, S. Kadish, Y. C. Lo, C. Mayo, S. McCauley, J. Meyer, R. Pieters, and A. Sherman, "The effect of radiation therapy on normal tissue function," Hematol Oncol Clin North Am, vol. 20, pp. 141-63, Feb 2006.